Can 2025 J.P. Morgan Healthcare Conference Spark Biotech M&A?

Seeking Alpha15:06 ET

Gilead in Pact for Anti-inflammatory Drugs in a Deal Worth up to $1.7B

Seeking Alpha11:40 ET

Bernstein Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $105

Moomoo News11:32 ET · Ratings

Express News | Gilead - Transaction With Leo Pharma Is Expected to Reduce Gilead’s Gaap and Non-Gaap 2025 EPS by Approximately $0.15 - $0.17

Reuters11:13 ET

Express News | Gilead - Leo Pharma Is Eligible to Receive up to $1.7 Billion in Total Payments, Including an Upfront Payment of $250 Million

Reuters11:12 ET

Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases

Businesswire11:00 ET